Data-driven design of targeted gene panels for estimating immunotherapy biomarkers
Authors:
Jacob R. Bradley,
Timothy I. Cannings
Abstract:
We introduce a novel data-driven framework for the design of targeted gene panels for estimating exome-wide biomarkers in cancer immunotherapy. Our first goal is to develop a generative model for the profile of mutation across the exome, which allows for gene- and variant type-dependent mutation rates. Based on this model, we then propose a new procedure for estimating biomarkers such as tumour mu…
▽ More
We introduce a novel data-driven framework for the design of targeted gene panels for estimating exome-wide biomarkers in cancer immunotherapy. Our first goal is to develop a generative model for the profile of mutation across the exome, which allows for gene- and variant type-dependent mutation rates. Based on this model, we then propose a new procedure for estimating biomarkers such as tumour mutation burden and tumour indel nurden. Our approach allows the practitioner to select a targeted gene panel of a prespecified size, and then construct an estimator that only depends on the selected genes. Alternatively, the practitioner may apply our method to make predictions based on an existing gene panel, or to augment a gene panel to a given size. We demonstrate the excellent performance of our proposal using data from three non-small cell lung cancer studies, as well as data from six other cancer types.
△ Less
Submitted 3 February, 2022; v1 submitted 8 February, 2021;
originally announced February 2021.
A Framework for Implementing Machine Learning on Omics Data
Authors:
Geoffroy Dubourg-Felonneau,
Timothy Cannings,
Fergal Cotter,
Hannah Thompson,
Nirmesh Patel,
John W Cassidy,
Harry W Clifford
Abstract:
The potential benefits of applying machine learning methods to -omics data are becoming increasingly apparent, especially in clinical settings. However, the unique characteristics of these data are not always well suited to machine learning techniques. These data are often generated across different technologies in different labs, and frequently with high dimensionality. In this paper we present a…
▽ More
The potential benefits of applying machine learning methods to -omics data are becoming increasingly apparent, especially in clinical settings. However, the unique characteristics of these data are not always well suited to machine learning techniques. These data are often generated across different technologies in different labs, and frequently with high dimensionality. In this paper we present a framework for combining -omics data sets, and for handling high dimensional data, making -omics research more accessible to machine learning applications. We demonstrate the success of this framework through integration and analysis of multi-analyte data for a set of 3,533 breast cancers. We then use this data-set to predict breast cancer patient survival for individuals at risk of an impending event, with higher accuracy and lower variance than methods trained on individual data-sets. We hope that our pipelines for data-set generation and transformation will open up -omics data to machine learning researchers. We have made these freely available for noncommercial use at www.ccg.ai.
△ Less
Submitted 26 November, 2018;
originally announced November 2018.
